NCT02734355View on ClinicalTrials.gov

Left Atrial Mechanical Function Improvement After Atrial Fibrillation Catheter Ablation

PHASE4CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

January 31, 2016

Study Completion Date

February 29, 2016

Conditions
Atrial Fibrillation
Interventions
DRUG

Telmisartan 80 mg and amlodipine 5 mg

DRUG

Placebo (for telmisartan and amlodipine)

Sugar pill manufactured to mimic telmisartan 80 mg and amlodipine 5 mg tablet

All Listed Sponsors
lead

Research Institute for Complex Problems of Cardiovascular Diseases, Russia

OTHER

NCT02734355 - Left Atrial Mechanical Function Improvement After Atrial Fibrillation Catheter Ablation | Biotech Hunter | Biotech Hunter